On August 28, 2019 Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) ("Rocket"), a leading U.S.-based multi-platform clinical-stage gene therapy company, reported participation at the following upcoming conferences (Press release, Rocket Pharmaceuticals, AUG 28, 2019, View Source [SID1234539072]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 14ᵗʰ Annual Biotech Conference
Wednesday, September 4, 2019
Baird’s 2019 Global Healthcare Conference
Gaurav Shah, M.D., President and CEO, is scheduled to present on Thursday, September 5, 2019, at 12:15 p.m. Eastern Time.
Morgan Stanley’s 17th Annual Global Healthcare Conference
Gaurav Shah, M.D., President and CEO, is scheduled to present on Wednesday, September 11, 2019, at 11:40 a.m. Eastern Time
Oppenheimer’s Fall Summit Focused on Specialty Pharma and Rare Disease Companies
Monday, September 23, 2019
Ladenburg Thalmann’s 2019 Healthcare Conference
Gaurav Shah, M.D., President and CEO, is scheduled to present on Tuesday, September 24, 2019, at 12:00 p.m. Eastern Time
A live audio webcast of the presentations will be available on the Investors section of the company’s website, www.rocketpharma.com. A replay of the presentations will be archived on the Rocket website following the conferences.